Dorman Products (NASDAQ: DORM) reported Q4 EPS of $1.01, $0.04 worse than the analyst estimate of $1.05. Revenue for the quarter came in at $501.3 million versus the consensus estimate of $445.72 million.

GUIDANCE:

Dorman Products sees FY2023 EPS of $5.15-$5.35, versus the consensus of $5.24. Dorman Products sees FY2023 revenue of $1.95-2 billion, versus the consensus of $1.95 billion.

For earnings history and earnings-related data on Dorman Products (DORM) click here.